GlobeNewswire Inc.··Novo NordiskNovo Nordisk Raises 2026 Outlook as Wegovy® Pills Exceed 2M Prescriptions
Novo Nordisk reported Q1 2026 adjusted operating profit of DKK 32.9B, raising 2026 guidance on Wegovy® pill's success with 2M total prescriptions since January launch.
NVOFDA approvalguidance raise